Resultats de la cerca - Hashimoto, Akihiro
- Mostrar 1 - 8 resultats de 8
-
1
-
2
-
3
Localization of the Optical Phonon Modes in Boron Nitride Nanotubes: Mixing Effect of (10)B Isotopes and Vacancies per Islam, Md. Sherajul, Howlader, Ashraful Hossain, Zheng, Rongkun, Stampfl, Catherine, Park, Jeongwon, Hashimoto, Akihiro
Publicat 2022Text -
4
Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways per Muraoka, Hiromi, Yoshimura, Chihoko, Kawabata, Rumi, Tsuji, Shingo, Hashimoto, Akihiro, Ochiiwa, Hiroaki, Nakagawa, Fumio, Fujioka, Yayoi, Matsuo, Kenichi, Ohkubo, Shuichi
Publicat 2019Text -
5
Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans per Zezula, Josef, Singer, Lisa, Przybyl, Anna K., Hashimoto, Akihiro, Dersch, Christina M., Rothman, Richard B., Deschamps, Jeffrey, Lee, Yong Sok, Jacobson, Arthur E., Rice, Kenner C.
Publicat 2008Text -
6
Probes for Narcotic Receptor Mediated Phenomena. 37.1 Synthesis and Opioid Binding Affinity of the Final Pair of Oxide-Bridged Phenylmorphans, the ortho- and para-b Isomers and The... per Kurimura, Muneaki, Liu, Hehua, Sulima, Agnieszka, Hashimoto, Akihiro, Przybyl, Anna K., Ohshima, Etsuo, Kodato, Shinichi, Deschamps, Jeffrey R., Dersch, Christina M., Rothman, Richard B., Lee, Yong Sok, Jacobson, Arthur E., Rice, Kenner C.
Publicat 2008Text -
7
High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells per Fujita, Hidenori, Gomori, Akira, Fujioka, Yayoi, Kataoka, Yuki, Tanaka, Kenji, Hashimoto, Akihiro, Suzuki, Takamasa, Ito, Kenjiro, Haruma, Tomonori, Yamamoto-Yokoi, Hiromi, Harada, Naomoto, Sakuragi, Motomu, Oda, Nobuyuki, Matsuo, Kenichi, Inada, Masaki, Yonekura, Kazuhiko
Publicat 2016Text -
8
TAS6417/CLN-081 is a pan-mutation-selective EGFR tyrosine kinase inhibitor with a broad spectrum of preclinical activity against clinically-relevant EGFR mutations per Udagawa, Hibiki, Hasako, Shinichi, Ohashi, Akihiro, Fujioka, Rumi, Hakozaki, Yumi, Shibuya, Mikiko, Abe, Naomi, Komori, Toshiharu, Haruma, Tomonori, Terasaka, Miki, Fujita, Ryoto, Hashimoto, Akihiro, Funabashi, Kaoru, Yasuda, Hiroyuki, Miyadera, Kazutaka, Goto, Koichi, Costa, Daniel B., Kobayashi, Susumu S.
Publicat 2019Text